Three mononuclear copper(II) complexes of the type [Cu(bba)(bpy/phen/dpa)](ClO 4 ) 2 (1-3), where bba (N,N-bis(benzimidazol-2-ylmethyl)amine) and bpy (2,2'-bipyridine, 1) or phen (1,10-phenanthroline, 2) or dpa (2,2'-dipyridylamine, 3), have been isolated. The coordination geometry of 1 around copper(II) is square pyramidal. The electronic absorption (639-667 nm) and EPR spectral parameters (g || , 2.25; A || , 181-186 × 10 -4 cm -1 ; g || /A || , 122−134 cm) reveal that 1-3 possesses a square pyramidal geometry with CuN 5 chromophore. Different spectral and electrochemical measurements clearly demonstrate partial intercalative interaction of 1-3 to CT DNA. Complexes strongly quench the intrinsic fluorescence of BSA through a static quenching procedure by forming BSA-(1/2/3) adducts, which are stabilized by hydrophobic interactions. The number of binding sites and binding constants were calculated. The energy transfer from BSA to Cu(II) complexes occurs with high probability. Notably, 1-3 exhibit more effective pUC 19 DNA cleavage in the presence of H 2 O 2 . Complexes 2 and 1 show remarkable cytotoxicity (IC 50 : 2, 2.17; 1, 8.33 M) against human cervical carcinoma cells (HeLa) and more potent than cisplatin (IC 50 , 16.40 M) while 3 exhibits less cytotoxicity (IC 50 , 20.82 M). The DNA binding propensity, cleavage ability and cytotoxicity follow the order 2>1>3. Interestingly, they are non-toxic to healthy cells.
Introduction
The serendipitous discovery of cisplatin [1] has revolutionized the cancer treatment; however, side-effects associated with the drug restrict its wider use [2] . Copper(II) complexes are regarded as promising and have attracted considerable attention owing to their capability of interacting directly with DNA and BSA [3, 4] . Many studies reveal that DNA is the primary intracellular target of anticancer drugs, since the interaction between small molecules and DNA able to cause DNA damage, block DNA synthesis in cancer cells [5] [6] [7] [8] . Therefore, under physiological conditions, metal complexes that possess efficient DNA binding and cleavage are regarded as potential candidates for use as therapeutic agents in medicinal applications and for genomic research [9] [10] [11] [12] . On the other hand, a vast majority of cytotoxic metal-containing compounds are administered intravenously, special consideration should be given to interactions of the metal drug with macromolecular blood components, which can then be taken up by and accumulate in tumor tissue. In this context, binding toward serum proteins, like albumin or transferrin that may perform a transport function for a metal. Such interactions determine the overall drug distribution and excretion and differences in efficacy, activity, and toxicity [13, 14] .
Benzimidazole moiety is structurally related to purine bases and is found in a variety of naturally occurring compounds such as vitamin B 12 . Benzimidazole derivatives display a wide variety of pharmacological properties including antitumor activity [15] and inhibition of nucleic acid synthesis [16] . Transition metal complexes consist of benzimidazole ligands act as cytotoxic [17, 18] , antiviral [18] and antiamoebic [19] agents. Moreover, ruthenium(I) [20] and zinc(II) [21] complexes of 2,6-bis(benzimidazol-2yl)pyridine have DNA cleaving properties. Copper(II) complexes with benzimidazolederived bidentate chelating ligands show most active cytotoxic activity [22] with different human tumor cell lines. There are also many examples in the literature of copper complexes of ligands containing -diimino (-N=C-C=N-) moiety such as phenanthroline that can induce apoptosis [23] and 2-(4'-thiazolyl)benzimidazole that display antimicrobial activity [24] . In particular, the non-planar nature of benzimidazole ligands, their flexibility, and bulkiness affect the kinetics and cytotoxic properties of the corresponding metal complexes. In addition, benzimidazole-based ligands can possess N-H moiety which can facilitate DNA cleavage in cancer cells [25] .
Thus, we have synthesized a series of mixed-ligand copper(II) complexes of the type [Cu(bba)(diimine)](ClO 4 ) 2 [where bba is N,N-bis(benzimidazol-2-ylmethyl)amine and diimine is 2,2'-bipyridine (1, bpy) or 1,10-phenanthroline (2, phen) or 2,2'dipyridylamine (3, dpa)] and investigated their interaction with calf thymus (CT) DNA and bovine serum albumin (BSA), DNA cleavage activity and in vitro cytotoxic properties against human cervical carcinoma cell line (HeLa) and normal mouse embryonic fibroblasts cell line (NIH 3T3).
Materials and Methods
Copper(II) perchlorate hexahydrate (Sigma Aldrich), 2,2′-bipyridine, 1,10-phenanthroline (Merck), 2,2'-dipyridylamine (Sigma Aldrich) and Tetra-N-butylammonium bromide (Thomas Baker) were used as received. The commercial solvents were distilled and then used for the preparation of ligand and complexes. The ligand N,N-bis(benzimidazol-2ylmethyl)amine (bba) was synthesized according to the published procedure [26, 27] . Calf thymus (CT) DNA and bovine serum albumin (BSA) were purchased from Sigma Aldrich and stored at -20 C. Ultrapure MilliQ water (18.2 m) was used for all the experiments.
The elemental analyses (C, H, N) were carried out using a Perkin-Elmer 2400 series II analyzer. The electrical conductivity was obtained with a Systronic 305 conductivity bridge, using 1×10 -3 M solution of the complex in dimethylformamide (DMF). Finnigan MAT TSQ-700 equipped with a custom-made electrospray interface (ESI) was used to perform mass spectrometry experiments. Spectra were collected by constant fusion of the analyte dissolved in DMF. Magnetic susceptibility value at 298 K was obtained using Model 300 Lewis-coil-force magnetometer of George Associate Inc. (Berkley, USA) make. The electronic spectra were recorded using Perkin-Elmer Lambda 35 UV-Visible spectrophotometer. The room temperature (RT) solid and liquid-nitrogen temperature (LNT) DMF solution electron paramagnetic resonance spectra were obtained on a JEOL JES-FA200 ESR spectrometer. All fluorescence measurements were performed using a Shimadzu RF-5301PC spectrofluorophotometer equipped with a thermostatic bath and a 10 mm quartz cuvette. The pH was potentiometrically measured using an Elico LI 120 pH meter equipped with a combined glass electrode. Cyclic voltammetry (CV) and differential pulse voltammetry (DPV) on glassy carbon disc electrode were performed in a CHI 620C electrochemical analyzer at 27  0.5 C. The working electrode was a glassy carbon disk (0.0707 cm 2 ), the reference electrode a saturated calomel electrode and the counter electrode a platinum wire. In DMF solution 0.1 M Tetra-N-butylammonium perchlorate and in buffer solution (pH 7.1) 2% DMF -5 mMTris-HCl/50 mMNaCl buffer was used as supporting electrolytes. Solutions were deoxygenated by purging with nitrogen gas for 15 min prior to measurements; during measurements, a stream of N 2 gas was passed over them. The redox potential E 1/2 was calculated from the anodic (E pa ) and cathodic (E pc ) peak potentials of CV traces as (E pa + E pc )/2 and as E p + E/2 (E is the pulse height) from the peak potential (E pa ) of DPV response.
Synthesis of copper(II) complexes
[Cu(bba)(bpy)](ClO 4 ) 2 (1): The complex 1 was prepared by adding a solution of copper(II) perchlorate hexahydrate (0.370 g, 1 mmol) in methanol (10 mL) to a 15 mL methanolic solution of 2,2′-bipyridine (bpy; 0.156 g, 1 mmol) and N,N-bis(benzimidazol-2-ylmethyl)amine (bba; 0.277 g, 1 mmol) and then stirring the solution for 2 h. The blue precipitate obtained was collected by suction filtration, washed with small amounts of cold methanol and diethyl ether and then dried in vacuum over P 4 The blue-colored crystals of 1 suitable for X-ray diffraction studies were obtained by dissolving the complex in DMF:MeCN mixture (1:5 v/v) and allowing it to crystallize at 5 C for 12 days.
[Cu(bba)(phen)](ClO 4 ) 2 (2): The complex 2 was prepared by adopting the procedure used for obtaining 1 by using 1,10-phenanthroline (phen; 0.180 g, 1 mmol) instead of bpy. Yield: 0.43 g (60%). Λ M (Ω −1 cm 2 mol −1 ) in DMF at 25 C: 161.  eff (solid, 298 K): 1.79  B . ESI-MS (CH 3 CN) displays a peak at m/z 260. 43 
X-ray crystallography
The crystal of 1 with dimensions 0.42×0.28×0.12 mm 3 was selected under the polarizing microscope and then mounted on the tip of glass fiber and cemented using epoxy resin. Intensity data for 1 was collected using Mo-K α ( = 0.71073 Å) radiation on a Bruker SMART Apex diffractometer equipped with a CCD area detector at 296 K. The SMART program [28] was used for collecting frames of data, indexing the reflections, and determining the lattice parameters. The data integration and reduction were processed with SAINT [29] software. Empirical absorption correction was applied to the collected reflections with SADABS [30] . The structure was solved by direct methods using SHELXS-97 [31] [32] [33] and was refined on F 2 by the full-matrix least-squares technique using the SHELXL-97 [31] [32] [33] program package. All the non-hydrogen atoms in 1 were refined anisotropically until convergence is reached. Hydrogen atoms attached to the ligand moieties were stereochemically fixed. The crystallographic data and details of data collection for 1 are given in Table 1 . 
DNA binding experiments
Solutions of DNA in the 2% DMF -5 mM TrisHCl/50 mM NaCl buffer gave a ratio of UV absorbances at 260 and 280 nm, A 260 /A 280 , of 1.9, representing that the DNA was free from protein [34] . Concentrated stock solutions of DNA (13.5 mol dm 3 ) were prepared in the buffer and sonicated for 25 cycles, where each cycle consisted of 30 s with 1 min intervals. After 1:100 dilutions, the UV absorbance at 260 nm ( 260 , 6600 dm 3 mol -1 cm -1 ) was used to estimate the concentration of DNA in nucleotide phosphate (NP). Stock solutions of DNA were kept at 4 C and used within 4 days. Concentrated stock solutions of copper(II) complexes were prepared by dissolving calculated amounts of the complexes in respective amounts of DMF and diluted suitably with the corresponding buffer to the required concentrations for all experiments. For absorption and emission spectral experiments, the DNA solutions were pretreated with solutions of copper(II) complex to ensure no change in concentrations of the copper(II) complex.
Absorption spectral titration experiments were performed by maintaining a constant concentration of the complex and varying the nucleic acid concentration. This was achieved by dissolving an appropriate amount of the metal complex and DNA stock solutions while maintaining the total volume constant (1 mL). This results in a series of solutions with varying concentrations of DNA but with a constant concentration of the complex. The absorbance (A) of the UV band of the complex was recorded after successive additions of CT DNA.
Emission intensity measurements were carried out using a Shimadzu RF-5301PC spectrofluorophotometer. The 2% DMF -5 mM Tris-HCl/50 mM NaCl buffer was used as a blank to make preliminary adjustments. Before measurements, the excitation wavelength was fixed and the emission range was adjusted. DNA was pretreated with ethidium bromide in the ratio [NP] : [EthBr] = 1:1 for 30 min at 27 C. The metal complex was then added to this mixture and their effect on the emission intensity was measured.
Protein binding experiments
The UV-Visible absorption spectra of 1.0 µM free BSA as well as BSA/copper(II) complex (equal molar ratio) in 0.5 M phosphate buffer of pH 7.4 were recorded from 200-500 nm.
Quantitative analyses of the interaction between copper(II) complex and BSA was performed by fluorimetric titration (0.5 M phosphate buffer, pH 7.4). A 3.0 mL portion of the aqueous solution of BSA (1.0  10 -6 mol L -1 ) was titrated by successive additions of complex (to give a final concentration of 8.0  10 -6 mol L -1 ). Titrations were done manually by using an Eppendorf micropipette. For every addition, the mixture solution was shaken and allowed to stand for 20 min at the corresponding temperature (300 and 310 K), and then the fluorescence intensities were measured with an excitation wavelength of 280 nm and emission wavelengths in the interval 290-500 nm. No correction for inner filter effect was applied since copper(II) complex represented very low absorbance (less than 0.1) at excitation and emission wavelengths. The excitation and emission slit width (each 5.0 nm), scan rate (fast) were constantly maintained for all the experiments. In the meantime, the synchronous fluorescence intensity of the mixture solution was measured at  = 15 nm and  = 60 nm, respectively.
DNA cleavage experiments
The interaction of complexes with supercoiled pUC19 DNA was monitored using agarose gel electrophoresis. In reactions using supercoiled pUC19 DNA, the plasmid DNA (SC form, 20 μM) in 2% DMF -5 mMTris-HCl/50 mMNaCl buffer solution at pH 7.2 was treated with copper complexes in the same buffer. In each experiment supercoiled pUC19 DNA was treated with different concentrations of complexes and also the cleavage of plasmid DNA in the absence and presence of the activating agent H 2 O 2 was monitored using agarose gel electrophoresis. The samples were then incubated for 2 h at 37 °C and analyzed for the cleaved products using gel electrophoresis as discussed below. A loading buffer containing 22% bromophenol blue, 0.22% xylene cyanol and 30% glycerol (3 μL) was added and electrophoresis was performed at 40 V for 6 h in Tris-acetate-EDTA (TAE) buffer (40 mM Tris base, 20 mM acetic acid, 1 mM EDTA) using 1% agarose gel containing 1.0 μg mL −1 EthBr. The gels were viewed in a Gel doc system and photographed using a CCD camera (Alpha Innotech Corporation). The cleavage efficiency was measured by determining the ability of complexes to convert the supercoiled DNA (SC) to nicked circular form (NC) and linear form (LC). In order to identify the reactive oxygen species (ROS) involved in the cleavage reaction the radical scavengers such as hydroxyl radical (DMSO, 6 μL), singlet oxygen (NaN 3 , 100 μM), superoxide (SOD, 4 unit), and H 2 O 2 (catalase, 6 units) were introduced.
Cell line
The human cervical cancer cell line (HeLa) was acquired from National Centre for Cell Science (NCCS), Pune. It was grown in Eagles Minimum Essential Medium containing 10% fetal bovine serum (FBS). The cells were preserved at 37 C, 5% CO 2 , 95% air and 100% relative humidity. Maintenance cultures were channelized weekly and the culture medium was altered twice a week.
Cell culture
To make single cell suspensions, the monolayer cells were detached with trypsinethylenediaminetetraacetic acid (EDTA) and viable cells were counted using a hemocytometer. They were diluted with medium containing 5% FBS to give a final density of 1×10 5 cells/mL. The cell suspension of one hundred microlitres per well were seeded into 96-well plates at a plating density of 10,000 cells/well. They were incubated to allow for cell attachment at 37 C, 5% CO 2 , 95% air and 100% relative humidity. The cells were treated with serial concentrations of the test samples after 24 h. They were dissolved in dimethylsulfoxide (DMSO) and an aliquot of the sample solution was diluted twice to the desired final maximum test concentration with serum-free medium. Also, four serial dilutions were made to give a total of five sample concentrations. Aliquots of 100 µL of different sample dilutions were added to the suitable wells already containing 100 µL of the medium, resulting in the required final sample concentrations. The plates were incubated followed by sample addition at 37 C, 5% CO 2 , 95% air and 100% relative humidity for an additional 48 h. The medium alone was served as control and triplicate was maintained for all concentrations.
Cell viability assay
The cell viability was carried out by using the MTT assay. Complex 1-3 in the concentration range 0.25-100 M dissolved in 2% DMF: 5 mMTris-HCl/50 mMNaCl buffer at pH 7.1 were added to the wells 24 h after seeding of 1×10 5 cells per well in 100 L of fresh culture medium. After 48 h, 15 µL of 3-[4,5-dimethylthiazol-2-yl]2,5diphenyltetrazolium bromide (MTT, 5 mg/mL) in phosphate buffered saline (PBS) was added to each well and incubated at 37 C for 4 h. The formed formazan crystals were solubilized in 100 µL of DMSO after the medium with MTT was flicked off. The microplate reader was used to measure the absorbance at 570 nm. Data were collected for three replicates each and the percentage cell viability and percentage cell inhibition was calculated using the following formulas:
% Cell viability = [A s ] / [A c ] × 100 (where A s is absorbance of sample and A c is absorbance of control).

% Cell inhibition = [100 -([A s ] / [A c ])] × 100
Nonlinear regression graph was plotted between % Cell inhibition and Log concentration and IC 50 was calculated using GraphPad Prism software.
Results and Discussion
Synthesis and general properties
The mixed ligand copper(II) complexes have been isolated in good yield (60-66%) by the reaction of bba and bpy or phen or dpa and copper(II) perchlorate hexahydrate in methanol at room temperature. All the complexes have been obtained as blue crystalline solids. Based on the elemental analysis the complexes were formulated as [(Cu(bba)(diimine)](ClO 4 ) 2 and the stoichiometry of 1 was confirmed by single crystal Xray structure determination. They show strong infrared spectral bands in the range 1528-1546 cm -1 and 1623-1638 cm -1 are assigned to  bzim (C=N) and  bzim (-C=N-C=C-) stretching vibrations respectively of the benzimidazole ring. The very strong band (1040-1048 cm -1 ) and a medium band (1081-1094 cm -1 ) are assigned to  bzim (C-N) stretching vibrations. The band in the range 3218-3245 cm -1 is due to  amine (N-H) stretching mode of bba ligand while the sharp and strong band (1543-1556 cm -1 ) is assigned to  py (C=N) stretching vibration of diimine ligands. The shift in the vibrational bands to lower energy implies the coordination of amine, benzimidazole, and pyridine nitrogens. 
Description of the crystal structure
The ORTEP view (Fig. 1a ) of 1 shows a discrete monomeric copper(II) complex dication and two perchlorate anions. The selected bond distances and bond angles relevant to the copper coordination sphere are given in Table 2 . (4) Cu (1) 103.82 (17) The value of the structural index [37] τ of 0.10 reveals that the coordination geometry around copper(II) is best described as square pyramidal [38, 39] with no significant distortion toward trigonalbipyramidal. The tridentate ligand bba is bound facially to Cu(II) with the two bzim nitrogens (Cu-N bzim , 1.987(4), 1.985(4) Å) located in the basal plane and the two imine nitrogens of bpy (Cu-N imine , 1.997(4), 1.994(4) Å) occupying the remaining corners of the basal plane. The strongly bound bpynitrogens occupy the equatorial sites around Cu(II) with the sterically hindered N7 amine nitrogen atom of bba defaulting to the more weakly bound z-axial position (Cu(1)-N(7), 2.412(5) Å) [27] . The displacement of copper atom above the N1N2N3N4 plane is 0.094 Å illustrating the importance of the steric effect of the bulky bzim moieties. The Cu-N bzim bond distances are similar to those observed for [Cu(bba)Cl 2 ] [40, 41] and [Cu(bba) 2 ] 2+ [27] . The axial Cu-N amine bond is longer than the equatorial Cu-N bpy bonds, which is expected of the presence of two electrons in the d z² orbital of Cu(II).
Interestingly, the molecular packing of 1 show two different self-assembled molecular associations between different adjacent molecules, viz. interactions between the molecules I and II and II and III (Fig. 1b) . The noticeable features are the presence of (i) inter-pair - interactions between bpy ligands (I and II) and (ii) C-H non-covalent interactions (II and III). The - stacking between C(3) of py and C(5) of py (C(3)C(5), 3.393 Å) rings of adjacent coordinated bpy ligands giving an average spacing of C g (p)C g (p) (C g (p), the centroid of the pyridine ring; 3.546 Å). Such an interaction is expected to stabilize the complex in the solid state [42] . Also, benzene rings of benzimidazole moiety of neighboring molecules display an attractive C-H non-covalent interaction. It gives C(15)-H(15)C(21) distance of 3.654 Å and the C(15)-H(15)C g (benzene) distance of 3.856 Å and C(15)-H(15)C g (benzene) angle of 160.02 (C g (benzene) is the centroid of the benzene in benzimidazole moiety) showing the closure approach and orientation of the neighbouring molecules [43] . Thus, the separation of CuCu between the adjacent molecules is 8.15 (I and II) and 10.69 Å (II and III).
Electronic and EPR spectral properties
The complexes (1-3) exhibit only one broad band ( max , 639-667 nm) in the visible region with very low  max value (70-120 M -1 cm -1 ), which is typical of a distorted square-based coordination geometry around copper(II). The strong absorption band is observed in the UV region ( max , 269-315 nm), which is attributing to the intraligand* transitions [44] from the coordinated diimines. The EPR spectra of 1-3 display one broad singlet (g iso , 2.053-2.066) in the polycrystalline state at 298 K arising from dipolar broadening and enhanced spin-lattice relaxation. The frozen DMF solution EPR spectra of the complexes are axial [g || >g  > 2.0; G = [(g || -2)/(g  -2)] = 4.9-5.1] suggesting the presence of d x²-y² ground state in copper(II) located in square-based geometries [45] . A square-based CuN 4 chromophore is expected [46] [47] [48] to show a g || value of 2.200 and A || value in the range 180-200 × 10 -4 cm -1 and a tetrahedral distortion from square planar coordination geometry or axial interaction would increase both the ligand field band position (cf. above) and g || value and decrease the A || value [46] [47] [48] . So, the observed values of g || (2.25) and A || (181-186 × 10 -4 cm -1 ) for 1-3 are consistent with the presence of a square-based CuN 4 chromophore with no significant distortion from planarity, as evident from the crystal structure of 1 (cf. above). This is supported by the values of g || /A || quotient (122−124 cm) falls in the range of 105-135 cm [49] . Molecular orbital coefficients [50] ,  2 (covalent inplane -bonding: 1, 0.83; 2, 0.82; 3, 0.81) and  2 (covalent in-plane -bonding; 1, 0.70; 2, 0.72; 3, 0.67) values show that there is a considerable interaction in the in-plane bonding while the in-plane -bonding is nearly covalent. For complexes 1-3, it is observed that K || >K  [51] (K || (1, 0.76; 2, 0.77; 3, 0.73) and K  (1, 0.69; 2, 0.70; 3, 0.65) are orbital reduction factors), illustrating the significant out-of-plane -bonding.
Electrochemical properties
The complexes are redox-active and show a one-electron quasi-reversible (ΔE p : 1, 198; 2, 128; 3, 206 mV) cyclic voltammetric responses in DMF for the Cu(II)/Cu(I) couple (E 1/2 : 1, -0.074; 2, -0.074; 3, -0.072 V vs SCE) with an i pa /i pc ratio (1, 0.9; 2, 1.0; 3, 0.9) of unity. Though the E 1/2 values are similar, the E pa (1, -0.173; 2, -0.138; 3, -0.175 V) and E pc (1, 0.025; 2, -0.010; 3, 0.031 V) values suggest the stability order for the copper(I) species as 2 (phen) >1 (bpy) >3 (dpa). A greater stabilization of the Cu(I) species for the phen complex is related to the planar phenyl moiety enhancing the -acidity of the ligand.
Notably, 2 shows very low E p value compared to 1 and 3, demonstrating the minimal structural reorganization between copper(II) and copper(I) species. It leads to a facile heterogeneous electron transfer [52] possibly due to the equatorial coordination of planar phen and bulky benzimidazoles of bba.
DNA binding studies
DNA is an important cellular target of many metallodrugs for the treatment of multiple pathologies including cancer. Thus, the binding ability of the complexes 1-3 with calf thymus (CT) DNA is characterized by measuring the effects on absorption, emission, and circular dichroism spectral and electrochemical techniques. The absorption spectra of 1-3 in the absence and presence of CT DNA at different concentrations R=25 (R=[DNA] / [Cu complex]; Fig. 2) show interesting changes in the intensity of intraligand absorption band (268 nm). This suggests the hypochromism for 1-3, typical of metal complex's association with the DNA helix. The strong hypochromic effect (61%) along with the 3 nm red shift for 2 reveals the partial intercalative [53] interaction through the active participation of planar phen moiety with DNA. However, the lack of red shift suggests that the binding mode of 1 and 3 (hypochromic effect: 1, 56; 3, 48%) was not intercalative. Because of the bulky structure of the complexes as well as the co-lignad is non-planar bpy (1) or dpa (3), the bzim rings cannot completely intercalate. When one of the two bzim rings inserts into the helix, the other ring extends away from the plane due to the stereochemistry effect and hence decreasing the effective area of overlap. Therefore, the observed spectral changes were rationalized in terms of feeble intercalation via bzim moiety in 1 and 3. To further illustrate the DNA binding strength, the intrinsic binding constant K b was determined for 1-3 which were found to be 3.26  10 4 M -1 (1), 3.49  10 4 M -1 (2), 3.11  10 4 M -1 (3). The binding constants were lower compared to classical intercalators (EthBr-DNA, 1.4  10 6 M -1 ) [54] , the diminution could be explained by the steric constraints imposed by the ligand framework and thus encouraging a partial intercalative binding mode for these complexes and it was found for many other compounds with the same order of K b values [55] .
The observed circular dichroic (CD) spectrum of CT DNA consists of a positive band at 273 nm owing to base stacking and a negative band at 243 nm owing to helicity which is typical of DNA in right-handed B-form. Upon incubation of CT DNA with 1-3, shows conformational changes: (i) the intensity of both the bands of CT DNA increases (1 and 3) with the red shift of 2-3 nm in the positive band and (ii) the intensity of positive band increases while the intensity of the negative band decreases (2) with the red shift of 3 nm in the positive band (Fig. 3) . These observations are consistent with the partial intercalative interaction through planar phen moiety (2) or bzim moiety (1 and 3) supporting the results from UV-vis spectroscopy. In competitive DNA binding experiment, with increasing amounts of 1-3, the fluorescence intensity of CT DNA-EthBr system (594 nm) was quenched (1, 89; 2, 96; 3, 76%) with the red shift of 5 nm (2) or 1 nm (1) or no shift (3) , which was due to the partial intercalation of copper(II) complexes to DNA base pairs displacing some EthBr from CT DNA-EthBr system (Fig. 4) [56] . The quenching data (K sv ) were analyzed according to the Stern-Volmer equation and the binding constant (K app ) value obtained using the equation, K EthBr [EthBr] = K app [Cu(II) Complex]. The K sv (1, 1.55  10 4 ; 2, 5.40  10 4 ; 3, 1.01  10 4 M -1 ) and K app (1, 1.54  10 5 ; 2, 2.06  10 5 ; 3, 1.03  10 5 M -1 ) values indicate that the complex 2 binds more strongly (via planar phen moiety) than the complexes 1 and 3 (via bzim moiety) through partial intercalative mode. The cyclic voltammograms of the complexes in the absence of DNA reveal a non-Nernstian but a fairly quasi-reversible (ΔE p : 1, 110; 2, 128; 3 , 111 mV) one electron redox process (i pa /i pc : 1, 1.0; 2, 1.2; 3, 1.0) involving the Cu(II)/Cu(I) couple (E 1/2 : 1 , -0 .0 8 9 ; 2 , -0 .0 9 1 ; 3 , -0 .0 8 5 V v s S CE ). Upon the addition of excess DNA (R = 5), the complexes show a significant reduction in both cathodic and anodic peak currents and reveal quasi-reversible (ΔE p : 1, 156; 2, 129; 3, 116 mV) one electron (i pa /i pc : 1, 1.0; 2, 1.1; 3, 1.2) electrochemical behavior for Cu(II)/Cu(I) couple (E 1/2 : 1, -0.193; 2, -0.191; 3, -0.198 V vs SCE). Interestingly, the reduction in both the peak currents indicates that the complexes bind through the partial intercalative mode and causes slow diffusion of an equilibrium mixture of the free and DNA-bound complexes to the electrode surface. Further, the observed shifts (104-127 mV) in E 1/2 values (DPV) to more negative potentials ( Fig. 5 ) suggest that both Cu(II) and Cu(I) forms of the present complexes bind to DNA but with Cu(II) displaying higher DNA binding affinity than Cu(I) form, which is substantiated by the ratio of the equilibrium constants (K + /K 2+ ) [57] . The K + /K 2+ values (1, 0.02; 2, 0.02; 3, 0.01) are far less than unity suggesting preferential stabilization of Cu(II) form over Cu(I) form on binding to DNA.
Protein binding studies
Three intrinsic flours present in the protein, such as tryptophan, tyrosine and phenylalanine residues are responsible for the fluorescence of protein. Actually, the intrinsic fluorescence of many proteins is caused mainly by tryptophan alone. Fluorescence quenching corresponds to any process, which is a reduction of the fluorescence intensity from a fluorophore due to a variety of molecular interactions such as molecular rearrangements, reactions at excited-state, energy transfer ground-state complex formation and collisional quenching. Thus, the emission spectra of BSA ( em , 340 nm;  ex , 280 nm) in the presence of increasing concentrations of 1-3 were recorded at 300 K and 310 K. The fluorescence intensity of BSA decreased regularly (Fig. 6 ), up to 61.6-74.4% (300 K) and 67.2-71.0% (310 K), accompanied by a hypsochromic shift of 3-14 nm (1 and 2) and bathochromic shift of 4-9 nm (3). The Stern-Volmer plots are linear [K SV : 300 K, 3.16 (1); 2.45 (2); 2.01 × 10 5 M -1 (3) and 310 K, 3.58 (1); 2.79 (2); 2.15 × 10 5 M -1 (3)] and suggest that a single quenching mechanism, either static or dynamic is occurred at these concentrations [58] . The quenching rate constant (k q ) is on the order of 10 13 M -1 s -1 , which is 1000-fold higher than the maximum limit (2.0 × 10 10 M -1 s -1 ) [59] , which indicates that the quenching is not initiated by dynamic collision but from the formation of the complex. On the other hand, upon addition of 1-3 to BSA, a significant decrease in 210 nm absorbance peak of BSA is observed (Fig. 7) , which is attributed, to the induced perturbation of -helix of BSA. Fig. 6 . Changes in the fluorescence spectra of BSA through the titration with 2 at 300 K (left), and 310 K (right). The concentration of BSA is 1 × 10 -6 mol L -1 , and the concentration of 2 was varied from (a) 0.0 to (k) 4.0 × 10 -6 mol L -1 ; pH 7.4 and  ex 280 nm. Meanwhile, the absorption intensity of the 280 nm band is increased due to the alteration in the microenvironment of three amino acid residues followed by the disturbance of the tertiary structure of BSA. Therefore the interaction between 1-3 and BSA leads to an adduct species which undergoes mainly a static quenching process [60] . The binding constant K b is decreased with increasing temperature [300 K, 0.83 (1); 0.73 (2); 1.42 × 10 5 M -1 (3) and 310 K, 0.42 (1); 0.60 (2); 0.78 × 10 5 M -1 (3)], which indicates the formation of stable BSA-(1/2/3) adduct and the number of binding site n is equal to 0.9 corresponds to the existence of a single binding site. So, the results suggest that the complex binds to the hydrophobic pocket located in subdomain IIA [61] . In order to elucidate the interaction forces of 1-3 with BSA, the thermodynamic parameters were calculated. The spontaneity of the interaction is revealed by negative G value. The positive values obtained for both H and S indicates that a hydrophobic association is the major binding force and that the interaction is entropy driven process [62] . Therefore, hydrophobic forces may play the main role in binding of 1-3 to BSA. In addition to hydrophobic interaction, a possible covalent bonding may be also considered, instead, the H value obtained (78-79 kJ mol -1 ) is less than the expected value for a covalent bond formation (≥120 kJ mol -1 ) [63] .
According to the theory of Miller [64] , when  between excitation wavelength and the emission wavelength is set at 15 or 60 nm, the synchronous fluorescence gives information about the molecular environment in a vicinity of tyrosine and tryptophan residues, respectively. The synchronous fluorescence spectra of BSA with various amounts of 1-3 were recorded at  = 15 nm and  = 60 nm ( Fig. 8) . It is apparent that the emission maxima of tyrosine and tryptophan residues have significant blue-shifted (tyrosine: 1, 314-299; 2, 314-308; 3, 314-303 nm and tryptophan: 1, 346-338; 2, 346-343; 3, 346-339 nm). The blue-shift expressed that the conformation of BSA was changed, leading to the decrease in polarity and increase in hydrophobicity around the tyrosine and tryptophan residues. For BSA-(1/2/3) system, the synchronous fluorescence quenching ratios, RSFQ at  = 60 nm (1, 74.7; 2, 70.3; 3, 72.1%) is greater than the corresponding one for  = 15 nm (1, 55.0; 2, 45.6; 3, 60.1%), indicating that 1-3 reached sub-domain IIA, where the only one Trp 212 residues on BSA was located.
In order to estimate the distance between the buried Trp-212 (as donor) and the interacted complex (as acceptor), Förster's non-radiative energy transfer theory (FRET) [65] was adopted. The overlap of the UV absorption spectra of Cu(II) complexes with the fluorescence emission spectra of BSA is made. The energy transfer efficiency is not only depending on the distance between the donor and acceptor, but also to the critical energy transfer distance (r), which should be less than 8 nm. According to the Förster's equations, we obtain J() (1, 4.33; 2, 8.02; 3, 3.08 × 10 15 M -1 cm 3 ), R 0 (1, 1.46; 2, 3.18; 3, 2.06 nm), E (1, 0.18; 2, 0.09; 3, 0.08) and r (1, 6.61; 2, 3.80; 3, 2.14 nm). The donor (Trp 212 in BSA) to acceptor (1-3) distance (r) is less than 8 nm [60] , indicates that the nonradiative energy transfer from BSA to Cu(II) complexes occurs with high possibility.
These accord with the conditions of FRET, indicating again the static quenching interaction between Cu(II) complexes and BSA [66] . 
DNA cleavage studies
The complex concentrations in the range 5-500 M, 1-3 fail to show any cleavage ( Fig. 9 ) when supercoiled (SC) pUC19 DNA (20 μM) was incubated with them in the absence of an activator in 2% DMF/5 mMTris-HCl/50 mMNaCl buffer at pH 7.1 for 1 h at 37 °C. Therefore, the ability of 1-3 to cause DNA cleavage was studied in the presence of H 2 O 2 .
In control experiments with DNA alone or DNA with H 2 O 2 alone no DNA cleavage is observed. At lower complex concentrations, 1 (20 μM), 2 (12 μM) and 3 (30 μM) convert SC DNA into nicked circular (NC) form and then to linear open circular (LC) form (Fig.  10 ) revealing the efficient cleavage like activity. As concentrations of 1-3 are increased, the amount of form I decrease while both forms II and III increase. Interestingly, even at 12 μM concentration, the cleavage ability of 2 is found to be more efficient and also exhibits the same percentage of cleavage of DNA from the form I to form II as in 1 and 3. The difference in the cleavage activity is due to the binding efficiency of the complexes to DNA (cf. Above). It means that 2 can intercalate into DNA owing to favorable planarity of the ligand phen, and that copper cation may coordinate with the negatively charged oxygen in the phosphodiester backbone of DNA, displacing a water molecule, which enhances the binding affinity between 2 and DNA. In the presence of H 2 O 2 as a reducing agent, Cu(II) complex is first reduced to form Cu(I) species and bound to DNA [67] , which reacts readily with H 2 O 2 to produce a peroxide complex such as DNA-Cu(I)OOH [68] . In the proximity of DNA, furthermore, the reduction of the peroxide complex (DNA-Cu(I)OOH) produces the ROS in abundance, i.e., hydroxyl radical, •OH, which would immediately attack the adjacent deoxyribose ring in the DNA skeleton. The preliminary mechanism of DNA strand scission by 1-3 has been investigated in the presence of several additives such as DMSO, superoxide dismutase (SOD), NaN 3 , and catalase. It is remarkable that SOD, NaN 3 and catalase are ineffective, rule out the possibility of DNA cleavage by 1 O 2 or O 2 − or H 2 O 2 and imply that •OH radicals are playing a role in the DNA cleavage reaction (Fig. 11 ). The strongly DNA bound complex 2 (through partial intercalation via planar phen moiety) is located near the cleavage site is stabilized more in the Cu(I) state and so shows higher DNA cleavage compared to 1 and 3 (through partial intercalation via bzim moiety) using the availability of H 2 O 2 since H 2 O 2 is needed for both oxidation and reduction steps.
In Vitro cytotoxicity studies
Several copper(II) complexes display efficient cytotoxic action and anticancer properties due to the higher DNA binding affinity and prominent DNA cleavage activity [69, 70] . Thus, as all the complexes strongly bind to DNA and induce efficient DNA cleavage, their cytotoxicity against human cervical carcinoma (HeLa) cell line has been investigated in comparison with the widely used drug cisplatin under identical conditions by using MTT assay. Their cytotoxicity was found to be concentration-dependent (0.25 to 100 μM) for 48 h incubation, which results in an increase in the percentage of cell inhibition (Fig. 12  CC) . The IC 50 values obtained reveal that the potency of the complexes to kill the cancer cells follows the order 2>1>>3, disclosing that the mode and extent of interaction of complexes with DNA dictate the cell killing ability (cf. above). The cell killing ability with 2 and 1 is remarkable in displaying cytotoxicity (IC 50 : 2, 2.17 (0.26); 1, 8.33 (0.16) μM), approximately 8 and 2 times more potent respectively than cisplatin (IC 50 , 16.41 (0.21) μM) [3] whereas 3 (IC 50 , 20.82 (0.09) μM) show relatively lower cytotoxicity. Notably, the highly remarkable cytotoxicity of 2 compares to 1 and 3 is attributed to the stronger binding of the complex through the partial intercalative insertion of planar phen ring between the base pairs and its higher cleavage activity is responsible for its potency to induce cell death. As a measure of therapeutic potential, we further determined the cytotoxicity of 1-3 against normal mouse embryonic fibroblasts cell line NIH 3T3 (Fig. 12  NC) . In general, they do not cause any damage toward NIH 3T3 (IC 50 > 100 μM), indicating that they are non-toxic to healthy cells, which is expected for a better drug.
Conclusion
The copper(II) complexes of the type [Cu(bba)(diimine)](ClO 4 ) 2 are involved in two types of partial intercalative mode of interactions with CT DNA, (i) via planar phen moiety in [Cu(bba)(phen)](ClO 4 ) 2 (2, stronger) and (ii) via bzim moiety in [Cu(bba)(bpy)](ClO 4 ) 2 (1, moderate) and [Cu(bba)(dpa)](ClO 4 ) 2 (3, weak) . The findings of the interaction mechanism of 1-3 with BSA are as follows: (a) strong quencher and interact with BSA through static quenching procedure; (b) the binding reaction is spontaneous; (c) hydrophobic interactions play a major role in the reaction; (d) affects the conformation of tryptophan residues micro-region and (e) the energy transfer occurs with high probability. These results support the fact that the Cu(II) complexes can bind to BSA and transport in the body. Further, the DNA binding, DNA cleavage and in vitro cytotoxicity studies show that the binding propensity, cleavage ability, and cell killing activity follow the order 2>1>3. Overall, these studies demonstrate that 2 is promising chemotherapeutic scaffold, with well-defined biological interactions and activity derived from the redox-active copper center.
